
Baxter International BAX
$ 19.52
1.93%
Quarterly report 2025-Q3
added 11-04-2025
Baxter International Cash Conversion Cycle 2011-2025 | BAX
Annual Cash Conversion Cycle Baxter International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 262 | 336 | 164 | 113 | 96.8 | 103 | 96.8 | 95.2 | 99.3 | 119 | 160 | 184 | 170 | 161 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 336 | 95.2 | 154 |
Quarterly Cash Conversion Cycle Baxter International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123 | 116 | 117 | 148 | 172 | 181 | 177 | 114 | 126 | - | 54.7 | 56.4 | 107 | - | 101 | 100 | 98.4 | 48.8 | 97 | 104 | 102 | 54 | 151 | 148 | 130 | 123 | 157 | 150 | 122 | 55.9 | 143 | 151 | 130 | 58.3 | 148 | 141 | 141 | 60.7 | 164 | 164 | 151 | 61.6 | 234 | 210 | 207 | 61.5 | 249 | 257 | 220 | 59 | 217 | 212 | 192 | 60.5 | 204 | 204 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 257 | 48.8 | 136 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
37.9 | $ 24.56 | 0.7 % | $ 1.13 B | ||
|
Becton, Dickinson and Company
BDX
|
110 | $ 200.48 | -0.23 % | $ 57.7 B | ||
|
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
266 | $ 4.68 | 0.21 % | $ 94.4 M | ||
|
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
208 | $ 0.71 | -4.45 % | $ 30.1 M | ||
|
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
143 | $ 148.28 | -0.1 % | $ 3.62 B | ||
|
iRhythm Technologies
IRTC
|
58.7 | $ 170.21 | 0.82 % | $ 5.31 B | ||
|
Alcon
ALC
|
134 | $ 79.15 | 0.43 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
185 | $ 41.07 | -3.09 % | $ 1.93 B | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
2.97 | $ 4.85 | 2.11 % | $ 26.7 K | ||
|
Repro Med Systems
KRMD
|
149 | $ 5.8 | 0.35 % | $ 264 M | ||
|
AngioDynamics
ANGO
|
124 | $ 13.42 | 2.13 % | $ 548 M | ||
|
The Cooper Companies
COO
|
210 | $ 81.36 | -0.88 % | $ 16.2 B | ||
|
LeMaitre Vascular
LMAT
|
28.7 | $ 83.04 | -1.14 % | $ 1.86 B | ||
|
Glaukos Corporation
GKOS
|
170 | $ 111.73 | 2.6 % | $ 5.41 B | ||
|
Masimo Corporation
MASI
|
83.7 | $ 137.35 | -0.72 % | $ 7.32 B | ||
|
Haemonetics Corporation
HAE
|
217 | $ 80.24 | -3.89 % | $ 4.04 B | ||
|
InfuSystem Holdings
INFU
|
24.9 | $ 9.22 | -0.27 % | $ 190 M | ||
|
Merit Medical Systems
MMSI
|
171 | $ 86.49 | -0.24 % | $ 5.04 B | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
208 | $ 559.7 | 3.2 % | $ 199 B | ||
|
OraSure Technologies
OSUR
|
167 | $ 2.49 | - | $ 185 M | ||
|
Microbot Medical
MBOT
|
-52.9 | $ 2.23 | -7.65 % | $ 22.7 M | ||
|
Milestone Scientific
MLSS
|
545 | $ 0.36 | -7.4 % | $ 28.7 M | ||
|
Nephros
NEPH
|
161 | $ 4.98 | -0.8 % | $ 51.7 M | ||
|
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | ||
|
ResMed
RMD
|
167 | $ 251.67 | -0.27 % | $ 36.8 B | ||
|
Envista Holdings Corporation
NVST
|
79.4 | $ 22.07 | 0.46 % | $ 3.8 B | ||
|
Pro-Dex
PDEX
|
193 | $ 44.0 | 1.43 % | $ 145 M | ||
|
STAAR Surgical Company
STAA
|
26 | $ 23.49 | -2.65 % | $ 1.15 B | ||
|
STERIS plc
STE
|
112 | $ 253.98 | 0.82 % | $ 25 B | ||
|
Stereotaxis
STXS
|
212 | $ 2.35 | -1.05 % | $ 190 M | ||
|
Pulse Biosciences
PLSE
|
36.5 | $ 14.04 | -1.4 % | $ 674 M | ||
|
Predictive Oncology
POAI
|
-241 | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
272 | $ 160.09 | 1.72 % | $ 8.92 M | ||
|
Utah Medical Products
UTMD
|
280 | $ 57.54 | -0.96 % | $ 209 M | ||
|
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.43 | -1.21 % | $ 2.32 B | ||
|
Retractable Technologies
RVP
|
250 | $ 0.84 | 1.99 % | $ 25.1 M | ||
|
Teleflex Incorporated
TFX
|
183 | $ 126.88 | 0.17 % | $ 5.94 B | ||
|
West Pharmaceutical Services
WST
|
98.9 | $ 271.82 | 1.6 % | $ 19.8 B |